Wondermed
UnverifiedUSD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
% growth | - | 33 % |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | $4.6m | Seed |
Total Funding | 000k |
Related Content
Recent News about Wondermed
EditWondermed is an innovative healthcare startup that operates in the mental health sector. The company offers a unique at-home treatment program for individuals suffering from anxiety and depression. The treatment is based on the use of ketamine, a substance that has been shown to potentially "rewire" the brain and disrupt harmful thought patterns, thus helping patients to form new, healthier pathways.
Wondermed's business model is centered around providing a comprehensive treatment package that includes self-led ketamine treatment sessions, a treatment kit, consultation with a Wondermed clinician, digital tools for support and integration, and musicologist-produced soundscapes. The company's approach is patient-centric, allowing patients to be in control of renewing their treatment, rather than providing automatic renewal.
The company's target market includes individuals suffering from anxiety and depression, particularly those who have not responded to other treatments. The company's treatment has been reported to significantly reduce symptoms of depression and anxiety, often after just a single treatment.
Wondermed generates revenue through the sale of its treatment packages. The company's use of ketamine, a substance that has been used in hospitals worldwide since 1970 and is FDA approved, adds credibility to its treatment approach.
In summary, Wondermed is a patient-focused healthcare startup that offers an innovative at-home treatment for anxiety and depression based on the use of ketamine.
Keywords: Healthcare, Startup, Mental Health, Anxiety, Depression, Ketamine, At-Home Treatment, Patient-Centric, Innovative, Treatment Package.